A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of two doses of FV-100 to
valacyclovir in patients with herpes zoster, or shingles. FV-100 has shown to be very potent
in cells infected with varicella zoster virus, the virus that causes shingles. The study
objectives include:
- Compare the safety of FV-100 to valacyclovir
- Compare the effect of FV-100, as compared to valacyclovir, on shingles pain
- Compare the effect of FV-100, as compared to valacyclovir, on shingles lesions